Devicemakers slow to embrace social media; Companies race to develop bionic eye;

 @FierceMedDev: Sonitus turns to Europe for the commercial rollout of its new hearing aid. It transmits sound through teeth. Release | Follow @FierceMedDev

 @MarkHFierce: Whites are more likely to be treated with CRT-D therapy than blacks and Hispanics, according to a new study. Article | Follow @MarkHFierce

 @DamianFierce: Hologic has to fork over $4M after losing a patent suit to Smith & Nephew. News | Follow @DamianFierce

> Medical device companies have been slow to embrace social media compared to other biotechs, with fewer than half the firms surveyed by Frost & Sullivan having any social media presence. Article

> SinuSys got a CE mark for the AerOs sinus dilation system, designed to open the sinus ostia to restore drainage and ventilation. News

> Bloomberg takes a look at the race to develop a bionic eye to help the world's 285 million blindness sufferers. Article

> Vertos Medical is squabbling with a doctor who, after administering a trial for a back pain-treating device, followed up with patients on his own and reported that the tech had failed them. Story

> Devicemaker Nordion reported net income of $12.3 million in its third quarter, a boost over the $4.1 million loss the company took in the same period last year. Item

> Germany's aap Implantate got 510(k) clearance for the small fragment plating line of its Loqteq trauma plating system. Release

> Continuing its campaign to cut back on how much radiation patients are exposed to, GE Healthcare ($GE) has partnered with Advocate Health Care to install its DoseWatch software for CT scans performed by the health system. More

Biotech News

 @FierceBiotech: HGS sharpens ax as restructuring claims 114 jobs. Item | Follow @FierceBiotech

 @JohnCFierce: Five down (as in 5 straight late-stage failures): Another Eli Lilly drug flunks a Phase III test. Article | Follow @JohnCFierce

> Zymeworks snags $11M, Merck milestone to fuel bi-specific antibody work. More

> Tufts: Cancer drugs win a speedier race to the FDA goal line. Story

> Merck KGaA grabs a cancer antibody hybrid in $625M Symphogen pact. News

Pharma News

 @FiercePharma: Jazz Pharma is selling its women's health business to Meda for $95M; 60 jobs to go along--APNews | Follow @FiercePharma

> Top Warner Chilcott investors to unload 43M shares. Article

> Public Citizen sues FDA over Aricept safety. News

> New Indian price caps would raise another hurdle to Big Pharma. Story

Vaccines News

> University of Oklahoma advances work on West Nile vaccine. Item

> Low HPV vaccination rates spur calls for wider use. Article

> Dendritic cells raise questions about cancer vax effectiveness. More

> ImmusanT launches U.S. trial for celiac vax. News

Pharma Manufacturing News

> Sun recalls biosimilar used for treating brain bleeding. More

> Under regulatory cloud, CEO says Novartis must boost quality. Article

> Competitors' manufacturing screw-ups keep Fresenius busy. Story

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.